Effect of the ebna‐2 gene on the surface antigen phenotype of transfected ebv‐negative B‐lymphoma lines

Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines

1973 • 1,718 citations

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

1982 • 878 citations

Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

1968 • 833 citations

A monoclonal antibody to human acute lymphoblastic leukaemia antigen

1980 • 748 citations

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

1987 • 735 citations

A study of malignant tumours in Nigeria by short-term tissue culture

1965 • 581 citations

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

1987 • 397 citations

Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

1975 • 390 citations

3 The normal and malignant germinal centre

1982 • 382 citations

Differences Between Laboratory Strains of Epstein-Barr Virus Based on Immortalization, Abortive Infection, and Interference

1974 • 279 citations

Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

1984 • 263 citations

Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.

1983 • 241 citations

Growth control of activated, synchronized murine B cells by the C3d fragment of human complement

1985 • 238 citations

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.

1986 • 230 citations

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.

1987 • 203 citations

Epstein-Barr virus susceptibility of normal human B lymphocyte populations.

1984 • 193 citations

gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.

1985 • 193 citations

Monoclonal antibody against a Burkitt lymphoma-associated antigen.

1981 • 171 citations

Establishment and characteristics of two unique cell lines from patients with lymphosarcoma

1974 • 154 citations

Monoclonal antibodies to epstein‐barr virus‐induced, transformation‐associated cell surface antigens: Binding patterns and effect upon virus‐specific t‐cell cytotoxicity

1982 • 151 citations

Biological differences between epstein-barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction

1975 • 143 citations

A Second Nuclear Protein Is Encoded by Epstein-Barr Virus in Latent Infection

1985 • 126 citations

Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

1984 • 111 citations

The Epstein-Barr Virus Proteins

1988 • 109 citations

The molecules controlling B lymphocytes

1987 • 104 citations

Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNA

1975 • 100 citations

Epstein‐Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma

1986 • 96 citations

Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation

1976 • 87 citations

Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings

1983 • 82 citations

Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro

1985 • 72 citations

Infection of EBV-Genome-Negative and – Positive Human Lymphoblastoid Cell Lines with Biologically Different Preparations of EBV

1974 • 61 citations

Expression of burkitt lymphoma‐associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal‐centre B cells

1985 • 59 citations

Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro

1985 • 58 citations

Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.

1985 • 44 citations

Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.

1985 • 41 citations

Chromosome mapping of cell membrane antigens expressed on activated B cells

1985 • 39 citations

Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome

1987 • 39 citations

Identification of Sequences in Epstein-Barr Virus DNA Required for the Expression of the Second Epstein-Barr Virus-determined Nuclear Antigen in COS-1 Cells

1987 • 36 citations

Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.

1983 • 34 citations

Interaction of the B95‐8 and P3HR‐1 substrains of epstein‐barr virus (EBV) with peripheral human lymphocytes

1978 • 20 citations

Cell Surface Glycoprotein Patterns of Two EBV-Negative Lines and Their EBV Converted Sublines

1981 • 8 citations